Skip to main content

Table 7 Per protocol analysis of mean and median wound survival time (days)

From: A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan

  Per protocol (PP) evaluation
  Group I Group II Group III Overall
Mean (95% CI) 69 (49-89) 33 (29-37) 45 (34-56) 49 (41-57)
Median (95% CI) 63 (47-79) 32 (27-37) 35 (21-49) 37 (31-43)